Apalutamide (APA) plus androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC): Analysis of pain and fatigue in the TITAN study Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Chung, B. H.; McQuarrie, K.; Bjartell, A.; Chowdhury, S.; Pereira de Santana Gomes, A. J.; Ozguroglu, M.; Juarez Soto, A.; Merseburger, A. S.; Uemura, H.; Ye, D.; Given, R.; Miladinovic, B.; Li, N.; Hudgens, S.; Floden, L.; Lopez-Gitlitz, A.; Chi, K. N.; Agarwal, N.

publication date

  • November 1, 2019


published in



  • 30